SCHEMBL502316

SCHEMBL502316

Cc1cc(O)cc(O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29577064 1.00
SCHEMBL275728 0.85
SCHEMBL3817409 0.78
SCHEMBL942172 0.78
SCHEMBL8608711 0.74
SCHEMBL13844134 0.74
SCHEMBL1674230 0.74
SCHEMBL19327477 0.74
SCHEMBL8351556 0.74
SCHEMBL31266597 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116036080-B Application of pyranopyridone compounds in preparation of medicines for treating liver cancer 江西省林业科学院 2023-06-06 CN claimed
CN-116178663-A Thermoplastic polyurethane elastomer composition and preparation method thereof 万华化学集团股份有限公司 2023-05-30 CN claimed
CN-116036080-A Application of pyranopyridone compounds in preparation of medicines for treating liver cancer 江西省林业科学院 2023-05-02 CN claimed
CN-112047878-B Preparation method of 4-bromo-6-chloropyridine-2-carboxylic acid 郑州猫眼农业科技有限公司 2022-04-19 CN claimed
CN-112047878-A Preparation method of 4-bromo-6-chloropyridine-2-carboxylic acid 郑州猫眼农业科技有限公司 2020-12-08 CN claimed
EP-4169575-B1 CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS SATO PHARMA (JP) 2026-01-07 EP disclosed
US-20250236621-A1 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES ENLIVEN INC. 2025-07-24 US disclosed
US-12240846-B2 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases ENLIVEN INC. (US) 2025-03-04 US disclosed
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
EP-4308575-A1 MACROCYCLES AS CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-01-24 EP disclosed
US-20230382907-A1 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES ENLIVEN INC. 2023-11-30 US disclosed
US-20230382907-A1 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES ENLIVEN INC. 2023-11-30 US disclosed
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US disclosed
US-20070281943-A1 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases JANSSEN PHARMACEUTICA N.V. (BE) 2007-12-06 US disclosed
WO-2006035967-A1 PYRIDINE DERIVATIVES AND THEIR USE AS MEDICAMENTS FOR TREATING DISEASES RELATED TO MCH RECEPTOR TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed
EP-0591105-B1 Bisazo, bisazomethine and azo-azomethine compounds CIBA SC HOLDING AG (CH) 2001-10-24 EP disclosed
US-5066695-A Plastics; heat resistance, dispersibility CIBA-GEIGY CORPORATION (US) 1991-11-19 US disclosed
EP-0369208-A1 Process for the preparation of 3,5-dimethyl-4-methoxy pyridine derivatives, and intermediate therefor Hafslund Nycomed Pharma Aktiengesellschaft (AT) 1990-05-23 EP disclosed
EP-0349489-A2 Organic macromolecular material containing a hydrazone-based metal complex pigment CIBA-GEIGY AG (CH) 1990-01-03 EP disclosed
US-3971741-A DISPERSION PIGMENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-27 US disclosed